128 results about "Oral Product" patented technology

An oral-product container is disclosed that includes: a) a plurality of breath fresheners contained therein for breath freshening purposes; and b) a mirror for visage freshening purposes.

The invention provides a high throughput, high purity, high yield system and method of isolating and purifying rebaudioside A (“Reb A”), with acceptable water solubility for all commercial uses, from commercially available Stevia rebaudiana starting material. The invention also provides a means of maximizing yields of 99+% purity Reb A based on the attributes of a given batch of Stevia starting material. The Reb A produced by the invention is water soluble, devoid of bitterness heretofore associated with rebaudioside sweeteners, non-caloric, and suitable for use as a reagent and as an ingredient in orally consumed products, e.g., as a sweetener, flavor enhancer, and flavor modifier.

A method of preparing low water-soluble medicine into solid nanometer pharmaceutical formulation is disclosed. According to the characters of molecular aggregates such as supramolecular chemical micelles and vesicles, the formulation, which based on the hydroxypropyl-beta-cyclodextrin and phospholipid, is prepared under the condition of hyperthermia sterilization and decompression. Such nanometer formulation is sterile particle or powder with loose porosity. For directly intravenous use, the formulation has targeting activity, sustained release and long circulating characters. While as a solid oral product, it is fast-release, fast-effective, and improved bioavailability characters, and is readily melted in mouth. The formulation utilizes secure accessories, traditional equipments and methods, thus, it is suited to be used and manufactured widely. Also disclosed is intravenous formulation of anticancer paclitaxel, which characterized that there has no polyoxyethylenated castor oil in it. Such intravenous formulation is nonallergic so that it has higher security and efficiency compared to present commercially available paclitaxel formulations.

A method of preparing low water-soluble medicine into solid nanometer pharmaceutical formulation is disclosed. According to the characters of molecular aggregates such as supramolecular chemical micelles and vesicles, the formulation, which based on the hydroxypropyl-beta-cyclodextrin and phospholipid, is prepared under the condition of hyperthermia sterilization and decompression. Such nanometer formulation is sterile particle or powder with loose porosity. For directly intravenous use, the formulation has targeting activity, sustained release and long circulating characters. While as a solid oral product, it is fast-release, fast-effective, and improved bioavailability characters, and is readily melted in mouth. The formulation utilizes secure accessories, traditional equipments and methods, thus, it is suited to be used and manufactured widely. Also disclosed is intravenous formulation of anticancer paclitaxel, which characterized that there has no polyoxyethylenated castor oil in it. Such intravenous formulation is nonallergic so that it has higher security and efficiency compared to present commercially available paclitaxel formulations.

The invention provides an oral product for promoting gastrointestinal tracts to absorb astaxanthin and a preparation method. The oral product comprises the following components in parts by weight: 60-120 parts of algae source astaxanthin, 5-50 parts of absorption-assisting auxiliary materials, soft-capsule forming auxiliary materials, tablet forming auxiliary materials and oral liquid auxiliary materials, wherein the soft-capsule forming auxiliary materials comprise gelatin, glycerol and water at the ratio of 1 to 0.4 to 1. The preparation method of various oral products comprises the following steps: 1 preparing soft capsule products; 2 preparing tablets; 3 preparing hard capsules; and 4 preparing oral liquids. The product provided by the invention is capable of promoting absorption of the astaxanthin by gastrointestinal tracts, and improving the bioavailability of the astaxanthin. The safe and effective gastrointestinal tract absorption accelerants are blended under the condition that the existing raw material character conditions are not changed, so that the bioavailability of the astaxanthin is enhanced; and the operation is simple.

The present invention relates to an oral health-care product of extract juice of mung bean as mother liquor. Its raw material composition includes (wt%) 60-70% of mung bean, 10-20% of jujube, 10-20% of lycium berry, 5-10% of pueraria root and 2-3% of lonicera. In the oral product of unit container the mung bean extract juice is 45-60% and other auxiliary material juice is 40-55%. Said invention adopts the chemical and physical combined cell breaking method to prepare mung bean juice, so its therapeutic effective componnet can be easily absorbed by human body. Said product can be made into beverage, oral liquor, powder or capsule, and passesses the functions of clearing away heat, removing toxic material, eliminating pimple and mark, beautifying face and moistening skin, etc.

The invention provides a medicinal or healthy compound for giving up smoking and relieving smoking cessation syndrome. The active ingredient at least comprises a nicotine class compound and / or a caffeine class compound instead of nicotine matter when smoking. In addition, the active ingredient further comprises a fructus momordicae extract. The medicine active ingredient in the compound is prepared through nanometer granulation to achieve the effect of being easy to be dispersed and convenient to be absorbed. The compound can further comprises one or a plurality of the following components for facilitating to relieve the smoking cessation syndrome that are a liquorice extract, a vitamin D compound, a salicylic acid compound and a coenzyme Q compound, and one or a plurality of the following auxiliary formulation matters that are a green tea extract, sorbitol and peppermint camphor. The compound which can be prepared into human oral product in various formulations effectively helps give up smoking, relieves the smoking cessation syndrome, eliminates fatigue, and relieves the oxidation or aging of cell tissues in human bodies.

The invention discloses an anhydrous matrix for oral products and application of the matrix, and belongs to the technical field of the oral products. The anhydrous matrix is characterized in that theoral products can stably exist when one of or both of a peroxide source and a cationic antibacterial agent are added into the matrix; the matrix is composed of propylene glycol, fumed silica and polyvinylpyrrolidone, and the weight ratio of the three components is 1:(0.03-015):(0.01-0.08). The cationic antibacterial agent can be a quaternary ammonium salt or a guanidine antibacterial agent, and can be didecyl dimethyl ammonium praline sodium (PODA) or cetylpyridinium chloride. The peroxide source can be a complex of urea peroxide or calcium peroxide, or percarbonate or perborate, or hydrogen peroxide, or polyvinylpyrrolidone hydrogen peroxide. The anhydrous matrix is used for preparing products for removing oral biofilm. The matrix achieves the effect that in the same system, the peroxidesource and the cationic antibacterial agent can stably coexist and synergistically inhibit and damage the biofilm.

The invention discloses an oral care product. A composition comprises 4 to 10 percent of red ginseng extract powder, 4 to 10 percent of extract powder of the root bark of the peony tree and 82 to 90 percent of clove extract oil; in the care product, the weight percentage of the composition is 0.5 to 10 percent, the weight percentage of auxiliary materials is 90 to 99.5 percent and the care product has a dosage form of a toothpaste or mouth wash. According to the extraction method of the composition in the oral care product, firstly, the root bark of the peony tree and red ginseng are smashed and decocted; filtrate is added into ethanol to be distilled to obtain extract powder; then mixing the extract powder and clove extract oil. The red ginseng and the root bark of the peony tree in the oral care product disclosed by the invention are refined by adopting a method of preparing the extract powder by concentration and distilment; by refining, effective component content can be increased, other impurities are reduced and the incidence irritability is reduced while the medicine effect is improved; when the oral care product adopts the toothpaste or mouth wash dosage form, the curative effect of the composition can be improved, the storage time of the composition is prolonged and the oral care product is convenient for a patient to use; the formula of integrating the red ginseng, the root bark of the peony tree and the clove extract oil into one whole body has strong capacity of preventing and treating gingivitis, stomatitis, halitosis and gingival pain and also enables gingiva to be strong and healthy.

An apparatus and method for forming a polymer film and / or oral dosage form having an active, content such as a vitamin, that is a considerable or relatively high proportion of the total dry weight percent without being unpleasant to taste, leaving a bitter after taste, having poor mouth feel and / or being slow to dissolve.